Peripheral neuropathy induced by microtubule-stabilizing agents.
about
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyPatient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice GuideNeurodegeneration and microtubule dynamics: death by a thousand cutsCancer-treatment-induced neurotoxicity--focus on newer treatmentsMechanisms involved in the development of chemotherapy-induced neuropathyNeuropathic cancer pain: What we are dealing with? How to manage it?Ixabepilone for the treatment of solid tumors: a review of clinical dataThe impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry.A model of toxic neuropathy in Drosophila reveals a role for MORN4 in promoting axonal degenerationVascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathiesnab-paclitaxel for the management of patients with advanced non-small-cell lung cancer.Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer.Presentation and management of docetaxel-related adverse effects in patients with breast cancerOutcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens.Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.Peripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptomsFoxM1 mediates resistance to herceptin and paclitaxel.Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trialsConservation of tubulin-binding sequences in TRPV1 throughout evolution.Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors.Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilonePhase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary.Ixabepilone development across the breast cancer continuum: a paradigm shift.Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancerOverview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Increased spinal cord Na⁺-K⁺-2Cl⁻ cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic painClinical trials and progress with paclitaxel in ovarian cancerPhase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors.Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in ratsDevelopment of a mouse model for assessing fatigue during chemotherapy.Models of Care in Geriatric Oncology.Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma.Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.Advances in tau-based drug discovery.Breast cancer medications and vision: effects of treatments for early-stage disease.
P2860
Q21261276-1FFD0A6C-B1C8-4563-970E-08D787F47974Q26749476-642578B0-3A2E-48B4-8A93-098C415D5227Q26781649-12F0D274-5F9B-435F-95A5-BFA21A3A0114Q26782604-FF97CBE3-CE39-4915-96C3-76C477726993Q26824380-CFD88F64-E96E-4F8E-88D3-6ACF52D4EAAFQ26998945-E2D43E8A-3A55-4DBC-8C33-C9E41170615CQ28271570-FC8ECDBB-A57D-4620-9F9A-14BCED3D0756Q30659496-3A281869-D7A8-407D-9125-B0D181AEA864Q33112264-1B27D9CA-BF9A-4955-844A-7F7F19ED97BCQ33324545-F8836B5E-E499-4B44-8558-5CD7EF277377Q33412928-40195803-098D-4A36-AF92-C23319C56DA1Q33530524-84D34307-8A40-48C6-A5EF-528555A7E5B9Q33698286-1501487E-8F00-4458-BE0B-DDCCC64C2E63Q33824842-919078FB-51D5-4CA4-A862-64B21FFCB426Q33824948-A5189B0F-1C61-4D72-934A-BDC513BA64A9Q33845533-9C050DDB-3ED0-4910-9DC8-1BFFEAD8CB5DQ33858197-8EC672A9-29E9-4849-8753-01F0C95C7C23Q33886036-DF980A80-212D-4F54-93ED-7497C45E354AQ33946664-1E85A989-23A9-4717-BF54-075C6F3F8AD7Q33953209-EFF82A53-02A8-4049-BF0F-96D757D582A2Q33984071-E3E3E14D-7F7A-457D-BEBD-69D444FF82F6Q34095827-488D9A93-A22D-43B8-88AC-BF13D2233388Q34180965-26A05708-33E4-42AE-A89D-81E8FFD2F96EQ34229765-63349454-39A2-48C1-8FF8-39E7D2BAD1CFQ34257256-FF77EB47-08DF-4E15-BB7F-917C9E411C1EQ34274930-74B3E0BD-3E56-4B9E-8594-F6AF88449DB8Q34307937-ED09F98A-245A-42E1-BCD9-A0F7798197ACQ34417996-6FD5C863-1EDC-4EBB-8599-98A0B2884EEFQ34418413-FE36ED12-397E-400A-82E1-447014DE1471Q34458581-691A35E4-8457-4AE1-B312-DD3B6EF7F827Q34467512-2B7FC0DD-CCD7-4513-BB42-0F1136198A6AQ34510070-4833F80D-38A5-44F3-AD0E-443E01D31BFDQ34687059-F44E22E3-E3C0-4FE1-ADFE-3AAE1C175765Q34802605-106934C8-A983-4559-AB42-B1763CC05AE7Q34819916-64251508-90B1-4B07-852E-2DE29D9A5166Q34902002-2F30D8C6-891D-4D6E-B62E-776D7A8C7024Q35051886-32BB962E-7A43-47AC-AA04-A843B55C4E24Q35187458-84A22683-F976-43EB-BF99-28F497EAAEABQ35321539-F68EE675-90AA-4DBE-AC42-469BD49FF42DQ35496778-B40BA498-24B2-4F58-B761-9BC2187D716B
P2860
Peripheral neuropathy induced by microtubule-stabilizing agents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Peripheral neuropathy induced by microtubule-stabilizing agents.
@ast
Peripheral neuropathy induced by microtubule-stabilizing agents.
@en
type
label
Peripheral neuropathy induced by microtubule-stabilizing agents.
@ast
Peripheral neuropathy induced by microtubule-stabilizing agents.
@en
prefLabel
Peripheral neuropathy induced by microtubule-stabilizing agents.
@ast
Peripheral neuropathy induced by microtubule-stabilizing agents.
@en
P356
P1476
Peripheral neuropathy induced by microtubule-stabilizing agents
@en
P2093
James J Lee
P304
P356
10.1200/JCO.2005.04.0543
P407
P577
2006-04-01T00:00:00Z